Roberto Piva

Roberto Piva

Università degli Studi di Torino - Torino / Italy
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 1856657
University of Turin
person_outline Roberto Piva's MOST POPULAR ARTICLES
1-) The anaplastic lymphoma kinase in the pathogenesis of cancerR Chiarle, C Voena, C Ambrogio, R Piva, G InghiramiNature Reviews Cancer 8 (1), 11-23, 20089362008
2-) Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell deathA Zamo, R Chiarle, R Piva, J Howes, Y Fan, M Chilosi, DE Levy, ...Oncogene 21 (7), 1038-1047, 20024472002
3-) Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphomaR Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ...Cancer cell 27 (4), 516-532, 20153912015
4-) CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomibR Piva, B Ruggeri, M Williams, G Costa, I Tamagno, D Ferrero, V Giai, ...Blood, The Journal of the American Society of Hematology 111 (5), 2765-2775, 20083312008
5-) NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumorsR Chiarle, JZ Gong, I Guasparri, A Pesci, J Cai, J Liu, WJ Simmons, ...Blood, The Journal of the American Society of Hematology 101 (5), 1919-1927, 20033122003